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Purpose: Previous research has shown dementia and mild cognitive impairment to 
be present in some Parkinson’s disease (PD) patients. Nevertheless, it is still not clear 
whether the impairment found in PD patients also comprises a facial emotion 
recognition deficit, nor it is whether this possible deficit is independent of the cognitive 
impairment or not. The aim of this study is to assess the presence of emotion 
recognition deficits in a sample of PD patients with normal cognitive abilities evaluated 
with several cognitive tasks widely used to detect cognitive impairment on this kind of 
patients 
Method: 40 non-demented (MMSE scores >25) PD patients and 19 healthy seniors 
matched on demographic characteristics took part in the study. All of them were 
evaluated with a neuropsychological battery including tests aimed to assess the 
cognitive domains mainly affected by PD, as well as a facial emotion recognition task. 
Results:  the scores in the 6 tasks that showed significant differences between PD 
and control groups according to a series of t-tests analyses were introduced in a 
sequential logistic regression analysis that confirmed the existence of a facial emotion 
recognition deficit in PD patients after controlling for demographic and cognitive 
characteristics of the participants.  
Conclusions: Although none of the PD patients fulfilled criteria for dementia, many 
of them appeared to present deficits on recognition of facial emotions. This task should 
therefore be incorporated into future research to study the full range of early cognitive 
dysfunctions and non-motor symptoms presents in PD patients, and inclusion of this 






Parkinson´s disease (PD) is a progressive neurodegenerative disorder typically 
diagnosed on the basis of the presence of motor symptoms (bradikinesia, rigidity and 
resting tremor). Those symptoms are the main consequence of the degeneration of 
dopamine neurons in the sustancia nigra [1]. However, other non-motor characteristics 
like hyposmia [2], sleep disorders, anxiety, depression, memory, language, executive 
function impairments and even dementia [3-5] are also present in many PD patients. 
Recent neuropathological findings have found that PD related pathology may extend to 
other brain areas including the dorsal motor nucleus of the vagus, the olfactory nuclei, 
the raphe nuclei, locus coeruleus, the reticular formation and some cortical regions [6] 
which could explain these non-motor symptoms. In addition, other symptoms like 
verbal and nonverbal communicative deficits remain partially unstudied, although they 
seem to be present in many PD patients. Thus, PD patients have been shown to present 
a reduced ability to produce spontaneous emotional expressions and co-speech gestures 
[7], as well as a specific impairment in recognising facial emotions [8,9]. The results of 
these studies suggest that the original description of PD should be updated into the 
concept of a multisystemic neurodegenerative disorder with multiple representations 
including non-motor symptoms such emotion recognition impairment [10]. 
The normal processing of facial emotions requires two different processes: 
perception and emotion recognition. Several brain areas situated in cortical and 
subcortical regions are related to the recognition of emotions from facial expressions, 
including the occipito-temporal cortex, the amygdala, the orbitofrontal cortex, the basal 
ganglia and the right parietal cortex [11]. Some of these areas, namely the nigrostriatal 
system, the amygdala and the insular cortex, have been demonstrated to be affected as a 
result of the PD-related pathology [6]. Recent neuroimaging studies have pointed out 
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the relationship between gray matter loss in the orbitofrontal cortex and facial emotion 
recognition impairments in early PD patients [12]. Furthermore, a relationship between 
facial emotion categorization impairments and strategies of facial expression scanning 
has been found in PD patients [5]. In contrast, other studies have failed to demonstrate 
the existence of impairment in facial emotion recognition tasks in PD patients compared 
to healthy controls [11]. 
Previous research represents an important contribution to our knowledge about non-
verbal deficits related to PD and has provided evidence for possible neuropathological 
substrates of these deficits. Thus, if only purely cognitive abilities are assessed, some 
information about non-motor symptoms related indirectly with cognitive process, like 
facial emotion recognition, could be ignored. Therefore, it seems necessary to design 
tasks that evaluate this nonverbal aspect of the patients that can affect their cognitive 
abilities and social behaviour in order to establish the full range of deficits associated to 
the disease and adequate the therapy. The aim of this study was to assess the presence of 
emotion recognition deficits in a sample of PD patients with apparently normal 
cognitive abilities assessed by means of several cognitive tasks widely used to detect 
cognitive impairment on this kind of patients. The appearance of some degree of 
emotion recognition impairment in our sample, even after demographic and cognitive 
characteristics have been controlled, would point out the existence of a specific and 
independent deficit related to facial emotion processing. 
METHOD 
Participants   
 A group of 40 regular follow-up PD patients (14 females) with a mean 
age of 69.62 (range 55-85) and a group of 19 healthy seniors (8 females) with a 
mean age of 74.31 (range 57-81) participated in the study. All of them had Mini 
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Mental State Examination [14] (MMSE) scores within the normal range (between 
27 and 30) according to the Escribano-Aparicio norms for Spanish population [15]. 
The two groups of participants were matched on demographic characteristics (see 
Table 1). PD patients had been diagnosed according to the UK Parkinson´s Disease 
Brain Bank criteria [16], prior to their participation in our study. All of them were 
studied on their dopaminergic treatment (Levodopa, agonists or both). Only patients 
that referred no subjective cognitive complaints or psychiatric and depressive 
symptoms (assessed with The Hospital Anxiety and Depression Scale [17] (HAD) 
took part in the study. Prior to the presentation of the experimental tests, the patients 
underwent a neuropsychological examination including the Tower of Hanoi, Stroop, 
and phonological (words beginning with the letter “p”), semantic (animals) and 
alternate fluency (a word beginning with the letter “p” and then animals, alternating 
both categories), as well as several tasks of the Barcelona Test-Revised [18], verbal 
and visual memory, attention, orientation, verbal comprehension and abstractions, to 
rule out dementia. Only native Spanish speakers with no history of alcohol abuse or 
neurological or psychiatric disorders other than PD were included in the study. 
Informed consent was obtained from all the participants. 
  Stimuli and tasks 
 The two groups of participants went through a test battery including facial 
emotion recognition tasks as well as other cognitive tasks frequently used with this 
kind of patients.  
- Facial emotion recognition: participants were asked to categorize the emotions 
expressed in 18 photos of faces (half male, half female) selected from the 
MacBrain Face Stimulus Set [19]. The faces could express one of six different 
emotions: happiness, sadness, anger, surprise, disgust or fear. 
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In order to rule out severe cognitive impairment or dementia, we selected several 
tasks to assess other capacities known to be affected in PD patients even at the early 
stages of the disease. Both standardized tests and newly designed tasks were 
combined in order to examine six cognitive domains: 
- Executive functions: the Go-nogo paradigm and Trail Making Test B (TMT-
B), as well as, phonological (letter “F”) and semantic (“tools”) and actions 
fluency tasks were used. 
- Memory: participants were orally presented with a list of ten words [20]. 
Immediately afterwards they were asked to recall as many words as possible, 
and once again after several minutes. In order to assess visual working 
memory, a grid including an increasing number of pseudorandomly distributed 
dots was presented for 10s. Then, the participant was asked to recall and mark 
the position of the dots. The task began with two dots and finished when the 
participant failed two consecutive items. This task was designed based on the 
visual memory task included in Wechsler´s. [21]. In addition, verbal working 
memory was assessed using forward and backward versions of the digit span 
task [18].  
- Attention: Trail making-A (TMT-A) and a visual search task where the 
participant had to mark the number 3 every time it appeared in a grid including 
randomly distributed figures from 1 to 9, were used to assess attention. This 
task was an adaptation of the attention task from the Barcelona test [18].  
- Visuospatial and constructive abilities: visuospatial abilities were assessed 
with dot and cube counting tasks from the Visual Object and Space Perception 
test [22] (VOSP). Participants were asked to count dots or cubes 
pseudorandomly distributed in a sheet of paper. Constructive abilities were 
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examined by means of the cube copy task from the Montreal Cognitive 
Assessment test [23] (MOCA) 
- Language: patients were asked to name 15 drawings of actions [24] using the 
infinitive form of a verb, and to produce the names of the famous persons from 
photographs of five national and five international celebrities. 
Procedure  
 PD patients were recruited between October 2009 and March 2010 and 
completed the neuropsychological assessment in a soundproof room of the Álvarez-
Buylla Hospital in Mieres, Asturias. Patients were evaluated in two sessions of about an 
hour that were scheduled 4 or 5 days apart. Each participant was run through the 
assessments individually.  
Statistical analysis 
 The scores of PD and control participants were compared by means of t-test 
analyses. Action and semantic fluency, visual search, action and famous faces naming 
as well as facial emotion recognition showed significant differences between the two 
groups. Then a sequential logistic regression analysis was conducted in order to test 
whether a facial emotion recognition deficit was apparent in our PD sample after 
controlling for demographic and cognitive characteristics of the participants. 
 
RESULTS 
 The mean (SD) scores of the two groups of participants in the 
neuropsychological battery are presented in Table 2. A summary of the results of the 
analysis is presented in Table 3.  
 A sequential logistic regression analysis was conducted in order to establish 
whether facial emotion recognition differentiated between PD and healthy controls after 
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controlling for demographic and cognitive characteristics of the participants. The first 
block of the analysis included participants’ socio-demographic characteristics, including 
age, sex and education (χ²(3)=4.48, p=.21; R²(Nagelkerke)=0.1). In the second block 
(χ²(4)=17.63, p=.001; R²(Nagelkerke)=0.44), scores obtained in the cognitive tasks that 
appeared to have a significant influence according to the results of the t-test, namely 
semantic and action fluency, action naming and visual search task attention, were 
introduced in the analysis. The third block (χ²(1)=10.57, p=.001; R²(Nagelkerke)=0.6) 
included the scores obtained in the famous faces naming task, and finally, scores 
obtained in the facial emotion recognition task were included in the fourth block 
(χ²(1)=19.19, p<.001; R²(Nagelkerke)=0.82). A summary of the results of the logistic 
regression is presented in Table 4. The final block of the regression showed a significant 
effect of the emotion recognition task even after controlling for all the other 
participants’ characteristics. Moreover, the model was able to accurately distinguish 
between healthy and PD participants in 91.5% of the cases. Thus, 94.7% of the healthy 
participants were classified correctly, whereas only 4 of the 40 PD participants were 
misclassified.  
 In order to provide a general description of the presence of cognitive deficits in 
the sample of PD patients studied, their scores were categorized as pathological if they 
were at least two standard deviations below the mean score of the control sample. 
Following this recent guidelines [25] 23 (57.5%) of the 40 patients were classified as 
cognitively intact, although 13 of them exhibited impaired emotion recognition. Taking 
into consideration the whole group of patients, 26 of them had an emotion recognition 




 Only a few studies aimed to assess the presence of emotion recognition 
impairment in Parkinson’s disease patients have been conducted, and their results are 
far from being consistent. Therefore, carrying out an experiment aimed to detect 
emotion recognition deficits in PD patients with normal cognitive abilities was 
considered necessary. A sample of 40 PD patients and 19 healthy seniors were assessed 
with an extensive neuropsychological battery exploring all cognitive domains mainly 
affected on PD such as executive functions, verbal fluency, attention, visuospatial 
abilities, memory and language to rule out dementia and severe cognitive impairment 
that could affect their performance on an emotion recognition  task. Besides, caregiver 
information about cognitive functioning and the neurologist subjective criteria were also 
taken into account. Nevertheless, our assessment revealed the existence of some degree 
of cognitive deterioration in 42.5% of the patients, whilst 57,5% was considered as 
cognitively intact. On the basis of their results in the different tasks, the patients were 
classified as cognitively impaired or not. The cognitive impairment label was applied 
when their scores were two SD below the control mean. According to this criteria [22], 
27 (42.5%) were considered to suffer from cognitive impairment, a rate consistent with 
those obtained in previous studies [29]. It should be noted, however, that many of the 
allegedly non-cognitively impaired patients, presented a facial emotion processing 
deficit, to the point that impaired scores on this task were evenly distributed through the 
impaired and intact patient subgroups.  
Furthermore, our data support the notion that some PD patients show an emotion 
recognition deficit in absence of other cognitive deficits that could explain it. This 
results suggest that the emotion recognition deficit is a different entity independent from 
other cognitive impairments.  The two tasks aimed to assess face processing (famous 
face naming and emotion recognition from facial expressions) revealed the existence of 
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deficits not directly related to those cognitive capacities. Moreover, a sequential logistic 
regression showed that facial emotion recognition was able to distinguish between 
healthy and PD participants after demographic and cognitive characteristics of the 
participants had been controlled. This deficit had already been described in previous 
research [8,9], and possible links with early dopamine depletion in the nigrostriatal 
system [27] or atrophy of the orbitofrontal cortex and amygdala[10] have been 
suggested to explain it. A number of studies have described mild executive dysfunction 
in early PD patients and the role of impaired cortico-basal connections in determining 
them [28]. However the fact that we have found facial emotion recognition deficits in 
PD patients with normal scores on executive function tasks argues against ascribing the 
emotional deficit to impaired cortico-basal connections. In contrast, our results are in 
line with data indicating that the amygdala could be damaged early during the course of 
Parkinson’s disease [12]. 
 In conclusion, the present study revealed the existence of an emotion processing 
impairment measured with facial emotion recognition in PD patients with normal global 
cognition and without subjective cognitive complaints.  
 According to our results, the assessment of face emotion recognitions should be 
incorporated to future research aimed to study the full range of non-verbal deficits 
present in PD patients in absence of pure dementia or severe cognitive impairment, and 
inclusion in assessment protocols should be considered in order to achieve a 
comprehensive description of the cognitive abilities present in PD patients.   
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